{
    "paper_id": "dbd56a723dcd7c0cd523fe24bffa300b1d0cca5a",
    "metadata": {
        "title": "Handbook of Critical and Intensive Care Medicine",
        "authors": [
            {
                "first": "J",
                "middle": [],
                "last": "Varon",
                "suffix": "",
                "affiliation": {},
                "email": ""
            }
        ]
    },
    "abstract": [],
    "body_text": [
        {
            "text": "B. Etiology. The most common causes of acute GI bleeding requiring admission to the intensive care unit (ICU) are depicted in Table 6 .1 . The most common sources of GI bleeding in the ICU are gastroduodenal stress ulcerations.",
            "cite_spans": [],
            "ref_spans": [
                {
                    "start": 126,
                    "end": 133,
                    "text": "Table 6",
                    "ref_id": "TABREF4"
                }
            ],
            "section": "Lower GI bleeding is below the ligament of Treitz."
        },
        {
            "text": "C. Diagnostic Evaluation 1. History Although the history and physical assessment in a critically ill patient with acute GI bleeding may be limited by the patient's clinical condition, the following are points that need to be investigated: ",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Lower GI bleeding is below the ligament of Treitz."
        },
        {
            "text": "The precise cause of acute GI bleeding is unlikely to be evident from physical examination alone (except in chronic liver disease, Osler-Rendu-Weber syndrome, or hemorrhoids). 3. A nasogastric (NG) tube should be placed in all patients with acute GI bleeding. The major advantages and disadvantages of NG tubes are shown in Table 6 .2 . ",
            "cite_spans": [],
            "ref_spans": [
                {
                    "start": 324,
                    "end": 331,
                    "text": "Table 6",
                    "ref_id": "TABREF4"
                }
            ],
            "section": "Physical Examination"
        },
        {
            "text": "All patients admitted to the ICU with GI bleeding should undergo the laboratory tests depicted in Table 6 .3 .",
            "cite_spans": [],
            "ref_spans": [
                {
                    "start": 98,
                    "end": 105,
                    "text": "Table 6",
                    "ref_id": "TABREF4"
                }
            ],
            "section": "Laboratory Evaluation"
        },
        {
            "text": "All patients should undergo chest radiograph and abdominal X-rays. These may show evidence of perforation or obstruction and may indicate ischemic changes.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Radiologic Evaluation"
        },
        {
            "text": "Contrast studies have a low diagnostic yield and may be hazardous for the critically ill patient. They may also interfere with other diagnostic studies (i.e., endoscopy, angiography). Special tests may be required in the evaluation of acute GI bleeding. These include: (a) Selective angiography may be used as a diagnostic as well as therapeutic tool (e.g., embolization). A bleeding rate \u22650.5 mL/min at the time of the procedure is needed for diagnosis. (b) Radionuclide scans are sensitive in detecting lesions with lower bleeding rates.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Radiologic Evaluation"
        },
        {
            "text": "6. Endoscopy is indicated in the vast majority of patients requiring ICU admission for GI bleeding.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Radiologic Evaluation"
        },
        {
            "text": "(a) Upper endoscopy is indicated when blood is obtained from the NG tube or when frank hematemesis is present. (b) Flexible sigmoidoscopy should be performed initially if lower GI bleeding is suspected. If this is not diagnostic, colonoscopy should be considered. (c) Special endoscopic procedures may be required (i.e., wireless video capsule endoscopy, push enteroscopy, double balloon enteroscopy).",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Radiologic Evaluation"
        },
        {
            "text": "D. Initial ICU Management 1. As in any critically ill patient, the management of acute GI bleeding starts with assessment of the airway, breathing, and circulation (ABCs). A low threshold for endotracheal intubation is recommended in the event of clouding of consciousness or overt shock, to prevent aspiration.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Radiologic Evaluation"
        },
        {
            "text": "2. Insert at least two large-bore (16-gauge) IV catheters.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Radiologic Evaluation"
        },
        {
            "text": "3. Infuse blood, plasma expanders, and/or normal saline to maintain a mean arterial pressure \u226565 mmHg.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Radiologic Evaluation"
        },
        {
            "text": "4. Some authors still recommend NG placement in all patients with GI bleeding and lavage of the stomach until the return is clear. This practice is considered useful only in settings where emergency endoscopy is not available. 3. Active Lower GI Bleeding (a) If a lesion is reachable with sigmoidoscopy or colonoscopy, local therapy may be attempted (e.g., laser coagulation). (b) Arterial embolization is indicated if the above fails. (c) All patients with active lower GI bleeding should receive surgical consultation in case an emergent intervention is needed.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Radiologic Evaluation"
        },
        {
            "text": "A. Defi nition. Acute mesenteric ischemia (AMI) is an acute reduction in blood fl ow to the intestine leading to inadequate perfusion. AMI may be a refl ection of generalized poor perfusion, or it may result from local pathology.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "II. ACUTE MESENTERIC ISCHEMIA"
        },
        {
            "text": "B. Epidemiology. The incidence of AMI has increased over the past few decades. The rising incidence may be attributable to advances in medical technology and to new therapies extending the life of critically ill patients who are prone to develop AMI (e.g., elderly). The mortality in AMI is between 55 % and 100 %. 3. Patients with suspected embolic or thrombotic occlusion should undergo urgent laparotomy for possible resection. Heparin and broad-spectrum antibiotic are indicated before surgery. Most patients will undergo a \"secondlook\" operation within 24 h of the initial laparotomy.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "II. ACUTE MESENTERIC ISCHEMIA"
        },
        {
            "text": "4. In those cases with nonocclusive AMI, intra-arterial infusions of vasodilators (e.g., papaverine 30-60 mg/h) are advocated by some.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "II. ACUTE MESENTERIC ISCHEMIA"
        },
        {
            "text": "A. Defi nition 1. Acute Fulminant Hepatic Failure Acute fulminant hepatic failure (FHF) is defi ned as acute liver failure associated with the development of hepatic encephalopathy within 8 weeks of the onset of symptoms attributable to hepatocellular dysfunction. This defi nition assumes that there is no preexisting liver disease.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "III. FULMINANT HEPATIC FAILURE AND ENCEPHALOPATHY"
        },
        {
            "text": "Hepatic encephalopathy (HE) is a complex neuropsychiatric syndrome precipitated by abnormal liver function. This syndrome is a feature of acute and/ or chronic hepatocellular failure.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Hepatic Encephalopathy"
        },
        {
            "text": "Common causes of FHF and HE are depicted in Table 6 .5 .",
            "cite_spans": [],
            "ref_spans": [
                {
                    "start": 44,
                    "end": 51,
                    "text": "Table 6",
                    "ref_id": "TABREF4"
                }
            ],
            "section": "B. Etiology"
        },
        {
            "text": "C. Diagnostic Evaluation 1. History A detailed history should be obtained from family members. The following points need to be investigated: Table 6 .6 .)",
            "cite_spans": [],
            "ref_spans": [
                {
                    "start": 141,
                    "end": 148,
                    "text": "Table 6",
                    "ref_id": "TABREF4"
                }
            ],
            "section": "B. Etiology"
        },
        {
            "text": "All patients with HE and/or FHF should undergo the following tests: (a) Chest X-ray, abdominal X-rays.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Laboratory and Radiologic Evaluation"
        },
        {
            "text": "(b) Blood glucose may reveal hypoglycemia. ",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Laboratory and Radiologic Evaluation"
        },
        {
            "text": "The development of renal failure with FHF carries a poor prognosis. (a) In most instances, the renal failure is related to \"prerenal\" causes. (b) The hepatorenal syndrome is a diagnosis of exclusion. It is associated with a normal urine sediment, a urinary sodium concentration of <20 mmol/L, and resolution if liver function improves.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Renal"
        },
        {
            "text": "Thrombocytopenia, diminished clotting factors with episodes of severe bleeding",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Hematologic"
        },
        {
            "text": "Susceptibility to infection is increased in patients with FHF.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Infection"
        },
        {
            "text": "Hypoglycemia, metabolic acidosis, hypokalemia, hyponatremia E. Management 1. Supportive Therapy (a) As in any critically ill patient, the management of AMI starts with assessment of the ABCs. (b) The usual indications for endotracheal intubation and assisted mechanical ventilation apply to these patients.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Metabolic"
        },
        {
            "text": "2. The use of corticosteroids for patients with FHF has not been proven to improve survival and, indeed, may worsen the clinical picture.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Metabolic"
        },
        {
            "text": "3. Some authors suggest avoiding parenteral nutrition, as protein and amino acids may worsen the clinical picture. However, new total parenteral nutrition solutions with \"branched-chain\" amino acids are probably effi cacious and help maintain a positive nitrogen balance.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Metabolic"
        },
        {
            "text": "4. The management of FHF-associated cerebral edema is no different from that for non-hepatic-related causes (see Chap. 9 , \"Neurologic Disorders\"). In recent years, emphasis on the use of therapeutic hypothermia for these patients seems encouraging.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Metabolic"
        },
        {
            "text": "Some clinical and experimental evidence shows that the benzodiazepine antagonist fl umazenil (Romazicon) may have some role in improving the signs and symptoms of HE.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "5."
        },
        {
            "text": "6. Investigational data have shown some improvement in the hemodynamics of patients with FHF treated with n-acetylcysteine.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "5."
        },
        {
            "text": "7. Liver transplantation may be an alternative form of therapy (in a few specialized transplant centers) for some patients with no known contraindication to the procedure. 8. Liver \"dialysis\": A few specialized centers are currently exploring this form of therapy.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "5."
        },
        {
            "text": "9. Agents aimed at stimulating ammonia metabolism have also been tried (e.g., ornithine-aspartate, sodium benzoate).",
            "cite_spans": [],
            "ref_spans": [],
            "section": "5."
        },
        {
            "text": "(g) C-reactive protein: Usually elevated.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "5."
        },
        {
            "text": "(h) Urinalysis may reveal proteinuria, casts (25 % of the cases), and glycosuria.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "5."
        },
        {
            "text": "Every patient with suspected acute pancreatitis should get a chest X-ray (to rule out free air under the diaphragm, evidence of pleural effusions, etc.) and an abdominal X-ray (signs of intestinal obstruction, ileus, gallstones, the so-called sentinel loop of pancreatitis, or the colon \"cutoff\" sign, etc.). In addition, when the diagnosis remains in doubt, especially in the more severely ill, the following can be obtained: (a) Ultrasonography (US) is the modality of choice in patients with edematous pancreatitis or suspected biliary pancreatitis and to follow up phlegmon or abscesses. Unfortunately, US cannot be accurately performed in obese patients and in those with moderate-to-severe ileus. (b) CT is the most useful tool in assessing the retroperitoneum. Its use in acute pancreatitis is mainly to follow up on signifi cant complications (i.e., abscess, phlegmon, pseudoaneurysms). Balthazar CT scoring system was the fi rst and is still in use. This scoring system includes fi ve grades: grade A (normal), grade B (pancreas enlargement), grade C (infl ammation of the pancreas and surrounding tissue), grade D (single peripancreatic fl uid accumulation), and grade E (two or more peripancreatic fl uid accumulation and/or air accumulation). Grade D and E have a mortality of 14 % and morbidity of 54 % (Table 6.7 ) . Therefore, contrast CT and necrosis classifi cation, found by Balthazar, were used simultaneously (CT Severity Index): grade 1 (<30 %), grade 2 (30-50 %), and grade 3 (>50 % necrosis) ( Necrosis of one-half of pancreas (50 %) 4",
            "cite_spans": [],
            "ref_spans": [
                {
                    "start": 1316,
                    "end": 1328,
                    "text": "(Table 6.7 )",
                    "ref_id": "TABREF4"
                }
            ],
            "section": "Radiologic Evaluation"
        },
        {
            "text": "Necrosis of more than one-half of pancreas 6 (>50 %) ",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Grade of acute pancreas points (Balthazar Score) Points"
        }
    ],
    "bib_entries": {
        "BIBREF0": {
            "ref_id": "b0",
            "title": "Many clinicians use the following agents in acute pancreatitis; however, clinical studies have not supported the routine use of these agents",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF1": {
            "ref_id": "b1",
            "title": "Calcitonin (300 IU/24 h)",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF2": {
            "ref_id": "b2",
            "title": "Somatostatin (250-\u03bcg IV bolus, then 250 \u03bcg/h as IV drip)",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF3": {
            "ref_id": "b3",
            "title": "Glucagon (d) Of interest is the use of intramuscular (IM) clonidine (not yet available in the United States) for patients hemodynamically stable with acute pancreatitis. Preliminary data show encouraging results",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF4": {
            "ref_id": "b4",
            "title": "Sedation and analgesia: Patients may require substantial amounts of analgesia, usually with meperidine (Demerol)",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF5": {
            "ref_id": "b5",
            "title": "Adequate parenteral nutrition (see Chap",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "10",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1007/978-3-319-31605-5_10"
                ]
            }
        },
        "BIBREF6": {
            "ref_id": "b6",
            "title": "Correct hypocalcemia only if there is clinical evidence of tetany",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF7": {
            "ref_id": "b7",
            "title": "The most common complications of acute pancreatitis are depicted in Table 6",
            "authors": [
                {
                    "first": "E",
                    "middle": [],
                    "last": "Complications",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "9",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF8": {
            "ref_id": "b8",
            "title": "Those patients who demonstrate fever >39 \u00b0C with a white blood cell count >20,000/mm 3 should be evaluated for the presence of a pancreatic abscess (with the use of CT). If there are any fl uid collections, CT-guided fi ne-needle aspiration is then indicated (for Gram's stain and cultures)",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF9": {
            "ref_id": "b9",
            "title": "Intravascular fluid depletion (a) Prerenal azotemia (b) Shock",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        }
    },
    "ref_entries": {
        "FIGREF0": {
            "text": "(a) History of hematemesis or melena (b) Time of onset (c) Amount of blood (d) Color and character (e) Drug or alcohol use (i.e., nonsteroidal anti-infl ammatory drug [NSAID], prednisone, warfarin) (f) Past medical history (i.e., cirrhosis, peptic ulcer disease [PUD], infl ammatory bowel disease [IBD], etc.)",
            "latex": null,
            "type": "figure"
        },
        "FIGREF1": {
            "text": "(a) General Appearance: This may vary from the patient in no acute distress to the patient in hypovolemic shock. (b) Vital Signs: Tachycardia and postural hypotension. An increase in heart rate of 10-20 beats per minute and drop in blood pressure of >20 mmHg upon assumption of an upright position are generally indicative of significant, acute volume loss.(c) Other Signs of Hypovolemia: Altered mental status and low urine output. (d) Associated Findings: Petechiae, jaundice, hepatomegaly, and splenomegaly. (e) Rectum: Look for hemorrhoids, fi ssures, etc. Examine stools for blood even if the patient has an upper GI source.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF2": {
            "text": "(a) History of preexisting liver disease (b) Drug or alcohol use (c) Toxin exposure or ingestion 2. Physical Examination This may vary from the patient in no distress to the patient in overt shock. (a) Vital signs: Tachycardia, hypotension. (b) Associated fi ndings: Petechiae, jaundice, hepatomegaly, splenomegaly. (c) The encephalopathy may begin with confusion, disorientation, and irrational behavior. Coma may develop rapidly. (See",
            "latex": null,
            "type": "figure"
        },
        "FIGREF3": {
            "text": "Serum bilirubin: A value >23 mg/dL is the best predictor of nonsurvival. (d) AST and ALT have little prognostic value as levels tend to fall as the patient's condition worsens. (e) Serum albumin: Its decrease refl ects poor outcome. (f) Serum electrolytes. (g) Complete blood count. (h) Head computed tomography (CT) scan to rule out a structural lesion (e.g., hemorrhage). (i) Lumbar puncture needs to be considered and performed if meningitis is suspected. (j) If the etiology of FHF is unknown, the following need to be ordered: 1. Acetaminophen level 2. Hepatitis profi le (a) Viral hepatitis A is diagnosed by detection of HAV-IgM in the patient's serum. (b) Viral hepatitis B is diagnosed by: (i) Detection of HBsAg (ii) Anti-HB c IgM (c) Viral hepatitis C is diagnosed by detection of anti-HCV. (d) Delta virus hepatitis is diagnosed by detection of anti-HDV in a patient coinfected with hepatitis B virus. 3. Alkaline phosphatase 4. Amylase (k) Serum ammonia level. (l) Electroencephalograms (EEGs) are used to assess clinical response and prognosis in patients with HE. D. Complications of FHF When the liver fails acutely, all organ systems are involved to some extent. 1. Central Nervous System (CNS) Hepatic encephalopathy, cerebral edema 2. Cardiovascular Dysrhythmias (particularly in patients with advanced FHF), hypotension 3. Pulmonary Hypoxemia advancing to adult (acute) respiratory distress syndrome (ARDS)",
            "latex": null,
            "type": "figure"
        },
        "TABREF0": {
            "text": "Etiologies of acute GI bleeding",
            "latex": null,
            "type": "table"
        },
        "TABREF1": {
            "text": "Bleeding advantages and disadvantages of NG tubes in acute GI",
            "latex": null,
            "type": "table"
        },
        "TABREF2": {
            "text": "Continuous bleeding for \u226548 h despite sclerotherapy and balloon tamponade. 3. Third acute episode of esophageal bleeding in spite of previous sclerotherapy. Other tests are ordered according to suspected or known underlying disease (i.e., LFTs, CK, etc.) BUN blood urea nitrogen, CK creatine kinase, FFP fresh-frozen plasma, H/H hemoglobin/hematocrit, LFT liver function tests, PRBCs packed red blood cells, PT prothrombin time, PTT partial thromboplastin time",
            "latex": null,
            "type": "table"
        },
        "TABREF3": {
            "text": "Barium studies are contraindicated in these patients and they interfere with arteriography. (c) Computed tomography (CT) may be particularly valuable when mesenteric vein thrombosis is being considered. It may show focal or segmental bowel wall thickening or intestinal pneumatosis. (d) Arteriography: For adequate study, the patient needs to be hemodynamically stable. Early use of this test is the key to diagnosis.",
            "latex": null,
            "type": "table"
        },
        "TABREF4": {
            "text": "",
            "latex": null,
            "type": "table"
        },
        "TABREF5": {
            "text": "Clinical stages of hepatic encephalopathy",
            "latex": null,
            "type": "table"
        },
        "TABREF6": {
            "text": "8 ). D. Management 1. As in any critically ill patient, the management of acute pancreatitis starts with assessment of the ABCs. Proton pump inhibitors (e.g., pantoprazole 40 mg IV q12 h) or H 2 -receptor blocking agents (e.g., ranitidine [Zantac] 300-mg/24 h IV infusion if renal function is normal or famotidine 20 mg IV q12 h).",
            "latex": null,
            "type": "table"
        },
        "TABREF7": {
            "text": "Grades of acute pancreatitis by points (Balthazar Score)",
            "latex": null,
            "type": "table"
        },
        "TABREF8": {
            "text": "Degree of pancreatic necrosis Degree of pancreatic necrosis PointsNecrosis of one-third of pancreas (30 %) 2",
            "latex": null,
            "type": "table"
        },
        "TABREF9": {
            "text": "Complications of acute pancreatitis",
            "latex": null,
            "type": "table"
        },
        "TABREF10": {
            "text": "10. Normal 24-h intestinal fl uid and electrolyte transport",
            "latex": null,
            "type": "table"
        },
        "TABREF11": {
            "text": "11. Child's classifi cation of portal hypertension",
            "latex": null,
            "type": "table"
        }
    },
    "back_matter": [
        {
            "text": "A. Defi nition. Acute pancreatitis is an infl ammatory process of the pancreas with a wide range of clinical severity ranging from self-limited to a lethal disease, complicated by multiple organ system failure (10 % of cases ",
            "cite_spans": [],
            "ref_spans": [],
            "section": "IV. PANCREATITIS"
        },
        {
            "text": "A. Intestinal Transit . The normal 24-h intestinal fl uid and electrolyte transport are depicted in Table 6 .10 .B. Stool Formulas . As part of the diagnostic workup of patients with diarrhea, stool osmolal gap (SOG) is usually calculated utilizing the following formula:SOG stool osmolality stool Na stool K = -\u00b4+ + + ( ) 2 Normal stool osmolality is <290 mOsm/L. If the SOG >100, it indicates an osmotic diarrhea.C. Liver Facts . The Child ' s classifi cation for portal hypertension is commonly used in critically ill patients and is depicted in Table 6 .11 .",
            "cite_spans": [],
            "ref_spans": [
                {
                    "start": 100,
                    "end": 107,
                    "text": "Table 6",
                    "ref_id": null
                },
                {
                    "start": 549,
                    "end": 556,
                    "text": "Table 6",
                    "ref_id": null
                }
            ],
            "section": "V. USEFUL FACTS AND FORMULAS"
        }
    ]
}